{"transactions":[{"id":692272,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-10T20:16:10.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":12103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reported securities are directly held by Jack Bendheim."}],"balance_after":26640,"source":{"system":"sec-edgar","filing":"0001104659-26-093385","document":"tm2622592-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926093385/tm2622592-3_4seq1.xml","form_type":"4"}},{"id":694547,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-07T00:12:30.000Z","date":"2026-08-04","kind":"other","planned":false,"acquired":false,"shares":2303,"price":36.599,"value":84287.497,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are directly held by Jack Bendheim."}],"balance_after":14537,"source":{"system":"sec-edgar","filing":"0001104659-26-092233","document":"tm2622506-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926092233/tm2622506-6_4seq1.xml","form_type":"4"}},{"id":788899,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-07","kind":"sale","planned":true,"acquired":false,"shares":2029,"price":49.1942,"value":99815.0318,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.50."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":56152,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":788898,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-07","kind":"sale","planned":true,"acquired":false,"shares":1149,"price":48.3074,"value":55505.2026,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.835."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":58181,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":788897,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-07","kind":"sale","planned":true,"acquired":false,"shares":1350,"price":47.5908,"value":64247.58,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.995."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":59330,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":788896,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-06","kind":"sale","planned":true,"acquired":false,"shares":1406,"price":58.1257,"value":81724.7342,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.965 to $58.31."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":60680,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":788895,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-06","kind":"sale","planned":true,"acquired":false,"shares":5634,"price":57.1752,"value":322125.0768,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.825 to $57.72."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":62086,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":788894,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":776,"price":56.365,"value":43739.24,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.235 to $56.51."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":67720,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":788893,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-07T23:34:44.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":6264,"price":55.7265,"value":349070.796,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.225 to $56.21. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 through 9."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":68496,"source":{"system":"sec-edgar","filing":"0001104659-26-057389","document":"tm2613857-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926057389/tm2613857-1_4seq1.xml","form_type":"4"}},{"id":797234,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-30","kind":"sale","planned":true,"acquired":false,"shares":1235,"price":53.3179,"value":65847.6065,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.22 to $53.39."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":74760,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":797233,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-30","kind":"sale","planned":true,"acquired":false,"shares":5805,"price":52.6473,"value":305617.5765,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.16 to $53.09."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":75995,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":797232,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-29","kind":"sale","planned":true,"acquired":false,"shares":3038,"price":53.2078,"value":161645.2964,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.775."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":81800,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":797231,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-29","kind":"sale","planned":true,"acquired":false,"shares":4002,"price":52.7005,"value":210907.401,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.97."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":84838,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":797230,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":797,"price":56.6896,"value":45181.6112,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.53 to $56.875."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":88840,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":797229,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":4591,"price":56.0607,"value":257374.6737,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.51 to $56.50."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":89637,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":797228,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-30T23:20:46.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":1652,"price":55.096,"value":91018.592,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.51 to $55.40. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 through 9."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":94228,"source":{"system":"sec-edgar","filing":"0001104659-26-053249","document":"tm2613153-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926053249/tm2613153-1_4seq1.xml","form_type":"4"}},{"id":802055,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-23T23:30:31.000Z","date":"2026-04-23","kind":"sale","planned":true,"acquired":false,"shares":421,"price":54.5582,"value":22969.0022,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.515 to $54.61."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":95880,"source":{"system":"sec-edgar","filing":"0001104659-26-047933","document":"tm2612536-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926047933/tm2612536-1_4seq1.xml","form_type":"4"}},{"id":802054,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-23T23:30:31.000Z","date":"2026-04-23","kind":"sale","planned":true,"acquired":false,"shares":6619,"price":54.0651,"value":357856.8969,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.51 to $54.50."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":96301,"source":{"system":"sec-edgar","filing":"0001104659-26-047933","document":"tm2612536-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926047933/tm2612536-1_4seq1.xml","form_type":"4"}},{"id":802053,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-23T23:30:31.000Z","date":"2026-04-22","kind":"sale","planned":true,"acquired":false,"shares":7040,"price":54.2876,"value":382184.704,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.73 to $54.665."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":102920,"source":{"system":"sec-edgar","filing":"0001104659-26-047933","document":"tm2612536-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926047933/tm2612536-1_4seq1.xml","form_type":"4"}},{"id":802052,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-23T23:30:31.000Z","date":"2026-04-21","kind":"sale","planned":true,"acquired":false,"shares":5415,"price":56.1656,"value":304136.724,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.91 to $56.56."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":109960,"source":{"system":"sec-edgar","filing":"0001104659-26-047933","document":"tm2612536-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926047933/tm2612536-1_4seq1.xml","form_type":"4"}},{"id":802051,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-23T23:30:31.000Z","date":"2026-04-21","kind":"sale","planned":true,"acquired":false,"shares":1625,"price":55.3501,"value":89943.9125,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.905 to $55.88. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5, 6 and 7."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":115375,"source":{"system":"sec-edgar","filing":"0001104659-26-047933","document":"tm2612536-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926047933/tm2612536-1_4seq1.xml","form_type":"4"}},{"id":807540,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-16","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19496034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807539,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-16","kind":"sale","planned":true,"acquired":false,"shares":1850,"price":54.8759,"value":101520.415,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.80 to $54.985."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":117000,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807538,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-16","kind":"sale","planned":true,"acquired":false,"shares":5190,"price":54.5552,"value":283141.488,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.80 to $54.79."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":118850,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807537,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-16","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":124040,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807536,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":799,"price":58.1126,"value":46431.9674,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.92 to $58.22."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":24040,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807535,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":3618,"price":57.2099,"value":206985.4182,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.90 to $57.88."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":24839,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807534,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":2623,"price":56.2691,"value":147593.8493,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $56.73."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":28457,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807533,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-14","kind":"sale","planned":true,"acquired":false,"shares":492,"price":59.6924,"value":29368.6608,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.63 to $59.83."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":31080,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":807532,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-17T00:25:42.000Z","date":"2026-04-14","kind":"sale","planned":true,"acquired":false,"shares":6548,"price":59.0338,"value":386553.3224,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.63 to $59.61. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5, 6, 7, 9 and 10."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":31572,"source":{"system":"sec-edgar","filing":"0001104659-26-044506","document":"tm2611963-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926044506/tm2611963-1_4seq1.xml","form_type":"4"}},{"id":824518,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-31T22:44:28.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":431,"price":54.3533,"value":23426.2723,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.28 to $54.51."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":38120,"source":{"system":"sec-edgar","filing":"0001104659-26-037978","document":"tm2610803-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926037978/tm2610803-1_4seq1.xml","form_type":"4"}},{"id":824517,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-31T22:44:28.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":6609,"price":53.8662,"value":356001.7158,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.27 to $54.26."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":38551,"source":{"system":"sec-edgar","filing":"0001104659-26-037978","document":"tm2610803-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926037978/tm2610803-1_4seq1.xml","form_type":"4"}},{"id":824516,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-31T22:44:28.000Z","date":"2026-03-30","kind":"sale","planned":true,"acquired":false,"shares":617,"price":54.309,"value":33508.653,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.23 to $54.385."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":45160,"source":{"system":"sec-edgar","filing":"0001104659-26-037978","document":"tm2610803-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926037978/tm2610803-1_4seq1.xml","form_type":"4"}},{"id":824515,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-31T22:44:28.000Z","date":"2026-03-30","kind":"sale","planned":true,"acquired":false,"shares":6423,"price":53.5415,"value":343897.0545,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.23 to $54.075. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5 and 6."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":45777,"source":{"system":"sec-edgar","filing":"0001104659-26-037978","document":"tm2610803-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926037978/tm2610803-1_4seq1.xml","form_type":"4"}},{"id":827610,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-26","kind":"sale","planned":true,"acquired":false,"shares":280,"price":57.1702,"value":16007.656,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.14 to $57.24."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":52200,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":827609,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-26","kind":"sale","planned":true,"acquired":false,"shares":6760,"price":56.7852,"value":383867.952,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.12 to $57.06."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":52480,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":827608,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":552,"price":56.8584,"value":31385.8368,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.76 to $56.91."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":59240,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":827607,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":4916,"price":56.0041,"value":275316.1556,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.76 to $56.745."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":59792,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":827606,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":1572,"price":55.2822,"value":86903.6184,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.69 to $55.65."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":64708,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":827605,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-24","kind":"sale","planned":true,"acquired":false,"shares":517,"price":53.5886,"value":27705.3062,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.53 to $53.70."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":66280,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":827604,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-27T01:19:23.000Z","date":"2026-03-24","kind":"sale","planned":true,"acquired":false,"shares":6523,"price":52.8772,"value":344917.9756,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.44 to $53.435. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 through 9."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":66797,"source":{"system":"sec-edgar","filing":"0001104659-26-035447","document":"tm269871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926035447/tm269871-1_4seq1.xml","form_type":"4"}},{"id":833915,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-19","kind":"sale","planned":true,"acquired":false,"shares":124,"price":53.24,"value":6601.76,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":73320,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":833914,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-19","kind":"sale","planned":true,"acquired":false,"shares":4977,"price":52.7864,"value":262717.9128,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.195 to $53.125."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":73444,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":833913,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-19","kind":"sale","planned":true,"acquired":false,"shares":1939,"price":51.7841,"value":100409.3699,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.19 to $52.18."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":78421,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":833912,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":2651,"price":53.6436,"value":142209.1836,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.365 to $53.88."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":80360,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":833911,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":3598,"price":53.0348,"value":190819.2104,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.35 to $53.295."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":83011,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":833910,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":4311,"price":51.798,"value":223301.178,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.29 to $52.21."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":86609,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":833909,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-19T23:58:21.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":5280,"price":51.659,"value":272759.52,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.26 to $52.13. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 through 8."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":90920,"source":{"system":"sec-edgar","filing":"0001104659-26-032252","document":"tm269323-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926032252/tm269323-1_4seq1.xml","form_type":"4"}},{"id":842421,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-03-16T20:15:15.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19596034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-26-028472","document":"tm268840-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926028472/tm268840-1_4seq1.xml","form_type":"4"}},{"id":842420,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-16T20:15:15.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":5280,"price":48.91,"value":258244.8,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.48 to $49.32. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":96200,"source":{"system":"sec-edgar","filing":"0001104659-26-028472","document":"tm268840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926028472/tm268840-1_4seq1.xml","form_type":"4"}},{"id":842419,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-16T20:15:15.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":101480,"source":{"system":"sec-edgar","filing":"0001104659-26-028472","document":"tm268840-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926028472/tm268840-1_4seq1.xml","form_type":"4"}},{"id":880255,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-27T00:09:08.000Z","date":"2026-02-26","kind":"sale","planned":true,"acquired":false,"shares":711,"price":54.2826,"value":38594.9286,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.27 to $54.355."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":1480,"source":{"system":"sec-edgar","filing":"0001104659-26-020787","document":"tm267373-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926020787/tm267373-1_4seq1.xml","form_type":"4"}},{"id":880254,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-27T00:09:08.000Z","date":"2026-02-26","kind":"sale","planned":true,"acquired":false,"shares":6329,"price":53.669,"value":339671.101,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.21 to $54.10."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":2191,"source":{"system":"sec-edgar","filing":"0001104659-26-020787","document":"tm267373-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926020787/tm267373-1_4seq1.xml","form_type":"4"}},{"id":880253,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-27T00:09:08.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":7040,"price":51.7104,"value":364041.216,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.275 to $52.27."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":8520,"source":{"system":"sec-edgar","filing":"0001104659-26-020787","document":"tm267373-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926020787/tm267373-1_4seq1.xml","form_type":"4"}},{"id":880252,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-27T00:09:08.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":1151,"price":51.8799,"value":59713.7649,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.065."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":15560,"source":{"system":"sec-edgar","filing":"0001104659-26-020787","document":"tm267373-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926020787/tm267373-1_4seq1.xml","form_type":"4"}},{"id":880251,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-27T00:09:08.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":5889,"price":51.2679,"value":301916.6631,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.755 to $51.75. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 through 7."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":16711,"source":{"system":"sec-edgar","filing":"0001104659-26-020787","document":"tm267373-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926020787/tm267373-1_4seq1.xml","form_type":"4"}},{"id":888852,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-23T21:30:23.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":397,"price":51.9644,"value":20629.8668,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.92 to $52.06."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":22600,"source":{"system":"sec-edgar","filing":"0001104659-26-018606","document":"tm266984-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926018606/tm266984-1_4seq1.xml","form_type":"4"}},{"id":888851,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-23T21:30:23.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":6643,"price":51.383,"value":341337.269,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.90 to $51.89."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":22997,"source":{"system":"sec-edgar","filing":"0001104659-26-018606","document":"tm266984-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926018606/tm266984-1_4seq1.xml","form_type":"4"}},{"id":888850,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-23T21:30:23.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":7040,"price":50.2568,"value":353807.872,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.965 to $50.935. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 and 5."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":29640,"source":{"system":"sec-edgar","filing":"0001104659-26-018606","document":"tm266984-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926018606/tm266984-1_4seq1.xml","form_type":"4"}},{"id":898190,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-19T00:40:44.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":216,"price":51.9688,"value":11225.2608,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.90 to $52.05."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":36680,"source":{"system":"sec-edgar","filing":"0001104659-26-017198","document":"tm266654-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926017198/tm266654-1_4seq1.xml","form_type":"4"}},{"id":898189,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-19T00:40:44.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":6824,"price":51.3774,"value":350599.3776,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.90 to $51.875."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":36896,"source":{"system":"sec-edgar","filing":"0001104659-26-017198","document":"tm266654-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926017198/tm266654-1_4seq1.xml","form_type":"4"}},{"id":898188,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-19T00:40:44.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":7040,"price":51.9633,"value":365821.632,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.61 to $52.345. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 and 5."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":43720,"source":{"system":"sec-edgar","filing":"0001104659-26-017198","document":"tm266654-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926017198/tm266654-1_4seq1.xml","form_type":"4"}},{"id":910530,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-11T23:27:20.000Z","date":"2026-02-11","kind":"sale","planned":true,"acquired":false,"shares":234,"price":52.2074,"value":12216.5316,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.205 to $52.21."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":50760,"source":{"system":"sec-edgar","filing":"0001104659-26-013602","document":"tm265965-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926013602/tm265965-1_4seq1.xml","form_type":"4"}},{"id":910529,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-11T23:27:20.000Z","date":"2026-02-11","kind":"sale","planned":true,"acquired":false,"shares":13950,"price":51.6107,"value":719969.265,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.11 to $52.04."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":50994,"source":{"system":"sec-edgar","filing":"0001104659-26-013602","document":"tm265965-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926013602/tm265965-1_4seq1.xml","form_type":"4"}},{"id":910528,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-11T23:27:20.000Z","date":"2026-02-10","kind":"sale","planned":true,"acquired":false,"shares":7020,"price":52.173,"value":366254.46,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.10 to $52.30."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":64944,"source":{"system":"sec-edgar","filing":"0001104659-26-013602","document":"tm265965-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926013602/tm265965-1_4seq1.xml","form_type":"4"}},{"id":910527,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-11T23:27:20.000Z","date":"2026-02-10","kind":"sale","planned":true,"acquired":false,"shares":50994,"price":51.7565,"value":2639270.961,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.10 to $52.09. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4, 5 and 6."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":71964,"source":{"system":"sec-edgar","filing":"0001104659-26-013602","document":"tm265965-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926013602/tm265965-1_4seq1.xml","form_type":"4"}},{"id":914900,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"exercise","planned":true,"acquired":false,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19696034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914899,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":19138,"price":49.5718,"value":948705.1084,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.18 to $50.01."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":122958,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914898,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":46275,"price":48.653,"value":2251417.575,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.175 to $49.17."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":142096,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914897,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":38209,"price":47.9055,"value":1830421.2495,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.17 to $48.17."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":188371,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914896,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":3171,"price":46.6816,"value":148027.3536,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.10 to $47.08."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":226580,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914895,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":3640,"price":45.4242,"value":165344.088,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.04 to $46.02."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":229751,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914894,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":409,"price":44.4688,"value":18187.7392,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.035 to $44.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 5 through 9."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":233391,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":914893,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-09T21:15:17.000Z","date":"2026-02-05","kind":"exercise","planned":true,"acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":233800,"source":{"system":"sec-edgar","filing":"0001104659-26-012073","document":"tm265586-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926012073/tm265586-1_4seq1.xml","form_type":"4"}},{"id":918155,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-02-06T00:22:29.000Z","date":"2026-02-04","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19881034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-011113","document":"tm265335-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926011113/tm265335-1_4seq1.xml","form_type":"4"}},{"id":918154,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T00:22:29.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":3520,"price":41.1544,"value":144863.488,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.535 to $41.52."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":48800,"source":{"system":"sec-edgar","filing":"0001104659-26-011113","document":"tm265335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926011113/tm265335-1_4seq1.xml","form_type":"4"}},{"id":918153,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T00:22:29.000Z","date":"2026-02-04","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":52320,"source":{"system":"sec-edgar","filing":"0001104659-26-011113","document":"tm265335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926011113/tm265335-1_4seq1.xml","form_type":"4"}},{"id":918152,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T00:22:29.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":2971,"price":41.9667,"value":124683.0657,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.70 to $42.62."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":22320,"source":{"system":"sec-edgar","filing":"0001104659-26-011113","document":"tm265335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926011113/tm265335-1_4seq1.xml","form_type":"4"}},{"id":918151,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T00:22:29.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":6689,"price":41.2508,"value":275926.6012,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.69 to $41.68. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 and 6."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":25291,"source":{"system":"sec-edgar","filing":"0001104659-26-011113","document":"tm265335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926011113/tm265335-1_4seq1.xml","form_type":"4"}},{"id":925696,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-02T21:15:18.000Z","date":"2026-01-30","kind":"sale","planned":true,"acquired":false,"shares":6693,"price":40.0941,"value":268349.8113,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.365."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":31980,"source":{"system":"sec-edgar","filing":"0001104659-26-009210","document":"tm264637-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926009210/tm264637-1_4seq1.xml","form_type":"4"}},{"id":925695,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-02T21:15:18.000Z","date":"2026-01-29","kind":"sale","planned":true,"acquired":false,"shares":6772,"price":40.1192,"value":271687.2224,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.475. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnote 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":38673,"source":{"system":"sec-edgar","filing":"0001104659-26-009210","document":"tm264637-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926009210/tm264637-1_4seq1.xml","form_type":"4"}},{"id":930333,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-01-27T21:15:13.000Z","date":"2026-01-26","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19911034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-006986","document":"tm264120-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926006986/tm264120-1_4seq1.xml","form_type":"4"}},{"id":930332,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-27T21:15:13.000Z","date":"2026-01-26","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":45445,"source":{"system":"sec-edgar","filing":"0001104659-26-006986","document":"tm264120-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926006986/tm264120-1_4seq1.xml","form_type":"4"}},{"id":930331,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-27T21:15:13.000Z","date":"2026-01-23","kind":"sale","planned":true,"acquired":false,"shares":1235,"price":40.5538,"value":50083.943,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.175 to $41.01. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":15445,"source":{"system":"sec-edgar","filing":"0001104659-26-006986","document":"tm264120-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926006986/tm264120-1_4seq1.xml","form_type":"4"}},{"id":933653,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-23T00:41:32.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":1283,"price":42.6774,"value":54755.1042,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.62 to $42.77."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":16680,"source":{"system":"sec-edgar","filing":"0001104659-26-005914","document":"tm263655-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926005914/tm263655-2_4seq1.xml","form_type":"4"}},{"id":933652,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-23T00:41:32.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":11875,"price":41.9086,"value":497664.625,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.58 to $42.53."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":17.963,"source":{"system":"sec-edgar","filing":"0001104659-26-005914","document":"tm263655-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926005914/tm263655-2_4seq1.xml","form_type":"4"}},{"id":933651,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-23T00:41:32.000Z","date":"2026-01-21","kind":"sale","planned":true,"acquired":false,"shares":14687,"price":41.6782,"value":612127.7234,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.11 to $42.02. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 and 5."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":29838,"source":{"system":"sec-edgar","filing":"0001104659-26-005914","document":"tm263655-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926005914/tm263655-2_4seq1.xml","form_type":"4"}},{"id":938684,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2026-01-15T23:24:00.000Z","date":"2026-01-14","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19941034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-26-004189","document":"tm263276-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926004189/tm263276-1_4seq1.xml","form_type":"4"}},{"id":938683,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T23:24:00.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":2932,"price":40.0233,"value":117348.3156,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.07."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":44525,"source":{"system":"sec-edgar","filing":"0001104659-26-004189","document":"tm263276-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926004189/tm263276-1_4seq1.xml","form_type":"4"}},{"id":938682,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T23:24:00.000Z","date":"2026-01-14","kind":"sale","planned":true,"acquired":false,"shares":393,"price":41.1375,"value":16167.0375,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.125 to $41.15."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":47457,"source":{"system":"sec-edgar","filing":"0001104659-26-004189","document":"tm263276-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926004189/tm263276-1_4seq1.xml","form_type":"4"}},{"id":938681,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T23:24:00.000Z","date":"2026-01-14","kind":"sale","planned":true,"acquired":false,"shares":3258,"price":40.4592,"value":131816.0736,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.025 to $40.985."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":47850,"source":{"system":"sec-edgar","filing":"0001104659-26-004189","document":"tm263276-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926004189/tm263276-1_4seq1.xml","form_type":"4"}},{"id":938680,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T23:24:00.000Z","date":"2026-01-14","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":51108,"source":{"system":"sec-edgar","filing":"0001104659-26-004189","document":"tm263276-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926004189/tm263276-1_4seq1.xml","form_type":"4"}},{"id":938679,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-15T23:24:00.000Z","date":"2026-01-13","kind":"sale","planned":true,"acquired":false,"shares":7551,"price":40.3154,"value":304421.5854,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.09 to $40.51. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 5, 6 and 7."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":31108,"source":{"system":"sec-edgar","filing":"0001104659-26-004189","document":"tm263276-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926004189/tm263276-1_4seq1.xml","form_type":"4"}},{"id":940332,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-13T23:53:02.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":213,"price":40.16,"value":8554.08,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":38659,"source":{"system":"sec-edgar","filing":"0001104659-26-003467","document":"tm262975-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926003467/tm262975-1_4seq1.xml","form_type":"4"}},{"id":943532,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-08T23:07:10.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":328,"price":40.0877,"value":13148.7656,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.035 to $40.26. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":38872,"source":{"system":"sec-edgar","filing":"0001104659-26-002221","document":"tm262516-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926002221/tm262516-1_4seq1.xml","form_type":"4"}},{"id":969986,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-15T21:51:38.000Z","date":"2025-12-11","kind":"sale","planned":true,"acquired":false,"shares":2995,"price":41.2167,"value":123444.0165,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.095 to $41.38."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":39200,"source":{"system":"sec-edgar","filing":"0001104659-25-121213","document":"tm2533388-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465925121213/tm2533388-1_4seq1.xml","form_type":"4"}},{"id":969985,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-15T21:51:38.000Z","date":"2025-12-11","kind":"sale","planned":true,"acquired":false,"shares":2757,"price":40.6096,"value":111960.6672,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.035 to $41.025. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnote 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":42195,"source":{"system":"sec-edgar","filing":"0001104659-25-121213","document":"tm2533388-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465925121213/tm2533388-1_4seq1.xml","form_type":"4"}},{"id":974905,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-10T21:15:20.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":1288,"price":40.1889,"value":51763.3032,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.01 to $40.34."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":44952,"source":{"system":"sec-edgar","filing":"0001104659-25-119982","document":"tm2533142-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465925119982/tm2533142-1_4seq1.xml","form_type":"4"}},{"id":974904,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-10T21:15:20.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":3520,"price":40.0618,"value":141017.536,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC (\"BFI\") on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.195. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnote 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":46240,"source":{"system":"sec-edgar","filing":"0001104659-25-119982","document":"tm2533142-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465925119982/tm2533142-1_4seq1.xml","form_type":"4"}},{"id":980607,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25172,"kind":"person","name":"BENDHEIM JACK","position":1,"cik":"0001241560","reported_name":"BENDHEIM JACK","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":25173,"kind":"organization","name":"BFI Co., LLC","position":2,"cik":"0001601607","reported_name":"BFI Co., LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2025-12-04T23:34:41.000Z","date":"2025-12-03","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by BFI Co., LLC (\"BFI\"). Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the \"Issuer\"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":19961034,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-25-118545","document":"tm2532723-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465925118545/tm2532723-1_4seq1.xml","form_type":"4"}}],"next_cursor":"2025-12-04T23:34:41.000000Z,980607"}